These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12466125)

  • 1. Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases.
    Zhu JH; Kulich SM; Oury TD; Chu CT
    Am J Pathol; 2002 Dec; 161(6):2087-98. PubMed ID: 12466125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells.
    Chalovich EM; Zhu JH; Caltagarone J; Bowser R; Chu CT
    J Biol Chem; 2006 Jun; 281(26):17870-81. PubMed ID: 16621793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases.
    Zhu JH; Guo F; Shelburne J; Watkins S; Chu CT
    Brain Pathol; 2003 Oct; 13(4):473-81. PubMed ID: 14655753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice.
    Santini E; Alcacer C; Cacciatore S; Heiman M; Hervé D; Greengard P; Girault JA; Valjent E; Fisone G
    J Neurochem; 2009 Feb; 108(3):621-33. PubMed ID: 19187092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease.
    Kulich SM; Chu CT
    J Neurochem; 2001 May; 77(4):1058-66. PubMed ID: 11359871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of reactive oxygen species in extracellular signal-regulated protein kinase phosphorylation and 6-hydroxydopamine cytotoxicity.
    Kulich SM; Chu CT
    J Biosci; 2003 Feb; 28(1):83-9. PubMed ID: 12682429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling.
    Weng Z; Signore AP; Gao Y; Wang S; Zhang F; Hastings T; Yin XM; Chen J
    J Biol Chem; 2007 Nov; 282(47):34479-91. PubMed ID: 17895242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease.
    Elkon H; Melamed E; Offen D
    Cell Mol Neurobiol; 2001 Dec; 21(6):771-81. PubMed ID: 12043847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
    Roux PP; Richards SA; Blenis J
    Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Hydroxydopamine induces mitochondrial ERK activation.
    Kulich SM; Horbinski C; Patel M; Chu CT
    Free Radic Biol Med; 2007 Aug; 43(3):372-83. PubMed ID: 17602953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation.
    Malagelada C; Ryu EJ; Biswas SC; Jackson-Lewis V; Greene LA
    J Neurosci; 2006 Sep; 26(39):9996-10005. PubMed ID: 17005863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra.
    Li LY; Zhao XL; Fei XF; Gu ZL; Qin ZH; Liang ZQ
    Acta Pharmacol Sin; 2008 May; 29(5):539-47. PubMed ID: 18430361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Synuclein forms a complex with transcription factor Elk-1.
    Iwata A; Miura S; Kanazawa I; Sawada M; Nukina N
    J Neurochem; 2001 Apr; 77(1):239-52. PubMed ID: 11279280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
    Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y
    Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of hippocampal Erk-1/2, Elk-1, and p90-Rsk-1 during contextual fear conditioning: interactions between Erk-1/2 and Elk-1.
    Sananbenesi F; Fischer A; Schrick C; Spiess J; Radulovic J
    Mol Cell Neurosci; 2002 Nov; 21(3):463-76. PubMed ID: 12498787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats.
    Cai G; Zhen X; Uryu K; Friedman E
    J Neurosci; 2000 Mar; 20(5):1849-57. PubMed ID: 10684886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosomal S6 kinase 1 (RSK1) activation requires signals dependent on and independent of the MAP kinase ERK.
    Richards SA; Fu J; Romanelli A; Shimamura A; Blenis J
    Curr Biol; 1999 Jul 29-Aug 12; 9(15):810-20. PubMed ID: 10469565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIGAR inclusion pathology is specific for Lewy body diseases.
    López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
    Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.